Literature DB >> 6775653

A human tumour-associated membrane antigen from squamous-cell carcinoma of the lung.

R W Veltri, P E Maxim, J M Boehlecke.   

Abstract

Primary human squamous-cell lung tumours were disrupted using mechanical high-speed homogenization. Crude membranes were isolated by differential centrifugation at low speeds followed by 100,000 g centrifugation. Such membrane preparations were extracted with Triton-X-100 and passed over a DEAE cellulose column; the DEAE unbound fraction and the bound fraction eluted with 0·4M NaCl were used to immunize rabbits. We present here only data on a single lung-tumour-associated membrane antigen (TAMA) found in the unbound DEAE cellulose column eluates. This new Triton-X-100 extractable antigen is termed lung TAMA-1.A further purification of the antigen was achieved using two methods. The first used G-200 molecular-seive chromatography and this revealed lung TAMA-1 to have a mol. wt of 200,000. A second method used sucrose density-gradient isoelectric focusing, and the antigen had an isoelectric point of ∼3·0.Several important properties of the lung TAMA-1 were determined. The antigen has a cathodal gamma-type electrophoretic mobility at pH 7·6. The antigen was not detected in any normal human adult or foetal tissue extracts tested. It did not crossreact immunochemically with CEA, AFP or β2 microglobulin. Lung TAMA-1 was detected in 80% of lung tumour Triton-X-100 extracts tested by counterimmuno-electrophoresis (CIEP) but was undetectable in breast or colon carcinoma extracts. Low frequency sonication did not deleteriously affect lung TAMA-1, but, 3M KCl eliminated its immunologic reactivity in CIEP. Finally, preliminary data were obtained using immunohistochemistry to localize in vivo lung TAMA-1 production.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775653      PMCID: PMC2010315          DOI: 10.1038/bjc.1980.132

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  [Antigens characteristic for tumors in bronchial carcinoma. 1 (author's transl)].

Authors:  H W Schlipköter; H Idel; A L Barsoum; U J Vollmer
Journal:  Zentralbl Bakteriol Orig B       Date:  1973-10

Review 2.  Reconstruction of biological membranes.

Authors:  S Razin
Journal:  Biochim Biophys Acta       Date:  1972-04-18

3.  Agarose-gel electrophoresis of soluble proteins from bronchial mucosa and bronchogenic carcinoma.

Authors:  C J Louis; J M Blunck; L M Richmond
Journal:  Oncology       Date:  1973       Impact factor: 2.935

4.  Tumor-specific antigen solubilized by hypertonic potassium chloride.

Authors:  M S Meltzer; E J Leonard; H J Rapp; T Borsos
Journal:  J Natl Cancer Inst       Date:  1971-09       Impact factor: 13.506

5.  Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.

Authors:  A C Hollinshead; T H Stewart; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

6.  Immunochemical studies on human lung cancer antigens soluble in 50 per cent saturated ammonium sulfate.

Authors:  A Yachi; Y Matsuura; C M Carpenter; L Hyde
Journal:  J Natl Cancer Inst       Date:  1968-04       Impact factor: 13.506

7.  Carbamylated human immunoglobulins tested by electrophoresis in agarose and antibody containing agarose.

Authors:  B Weeke
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

8.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

9.  Detection of neoantigens in the serum of patients with active neoplastic diseases by the absorption-immunodiffusion method.

Authors:  S DeCarvalho
Journal:  Oncology       Date:  1973       Impact factor: 2.935

10.  Mouse histocompatibility isoantigens derived from normal and from tumour cells.

Authors:  D A Davies
Journal:  Immunology       Date:  1966-08       Impact factor: 7.397

View more
  2 in total

1.  Antibody response to a solubilized tumor-associated membrane antigen (TAMA) from the murine Lewis lung tumor.

Authors:  J R McKolanis; R W Veltri
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  Collaborative study of bronchial tumour-associated antigens.

Authors:  J N Gennings; K D Bagshawe; N H Axelsen; P Sizaret
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.